GC Biopharma Corp. (KRX:006280)
South Korea
· Delayed Price · Currency is KRW 135,100
-2,100 (-1.53%)
Last updated: Dec 5, 2025, 11:06 AM KST
GC Biopharma Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 64,085 | 22,563 | 49,706 | 105,366 | 186,060 | 232,288 | Upgrade
|
| Short-Term Investments | -0 | 0 | 0 | -0 | - | - | Upgrade
|
| Trading Asset Securities | 4,432 | 1,432 | 5,800 | 6,940 | 16,875 | 23,210 | Upgrade
|
| Cash & Short-Term Investments | 68,517 | 23,995 | 55,506 | 112,306 | 202,935 | 255,498 | Upgrade
|
| Cash Growth | 46.82% | -56.77% | -50.58% | -44.66% | -20.57% | 80.53% | Upgrade
|
| Accounts Receivable | 541,325 | 386,526 | 436,957 | 394,155 | 413,817 | 402,088 | Upgrade
|
| Other Receivables | 7,182 | 9,635 | 11,976 | 13,778 | 9,624 | 20,598 | Upgrade
|
| Receivables | 549,906 | 404,812 | 450,933 | 409,433 | 423,987 | 422,736 | Upgrade
|
| Inventory | 849,437 | 746,582 | 516,245 | 442,408 | 454,976 | 437,071 | Upgrade
|
| Prepaid Expenses | 12,983 | 9,638 | 4,147 | 4,157 | 3,275 | 9,513 | Upgrade
|
| Other Current Assets | 13,644 | 16,806 | 12,316 | 12,133 | 5,346 | 7,223 | Upgrade
|
| Total Current Assets | 1,494,487 | 1,201,833 | 1,039,148 | 980,437 | 1,090,519 | 1,132,042 | Upgrade
|
| Property, Plant & Equipment | 952,766 | 915,826 | 952,703 | 930,822 | 899,847 | 751,099 | Upgrade
|
| Long-Term Investments | 206,258 | 225,340 | 206,646 | 216,273 | 110,962 | 92,030 | Upgrade
|
| Goodwill | - | 125,614 | 142,475 | 142,475 | 142,475 | 10,065 | Upgrade
|
| Other Intangible Assets | 438,338 | 72,535 | 86,166 | 76,735 | 57,240 | 31,797 | Upgrade
|
| Long-Term Accounts Receivable | 210 | - | - | - | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 61,169 | 49,941 | 35,185 | 27,839 | 19,832 | 20,686 | Upgrade
|
| Long-Term Deferred Charges | - | 109,236 | 109,240 | 92,353 | 77,691 | 67,702 | Upgrade
|
| Other Long-Term Assets | 38,020 | 43,272 | 68,972 | 53,824 | 63,299 | 45,700 | Upgrade
|
| Total Assets | 3,191,528 | 2,743,876 | 2,643,314 | 2,525,537 | 2,462,145 | 2,151,400 | Upgrade
|
| Accounts Payable | 248,804 | 156,818 | 143,816 | 121,270 | 119,541 | 134,785 | Upgrade
|
| Accrued Expenses | 68,101 | 40,073 | 34,000 | 102,066 | 85,781 | 82,684 | Upgrade
|
| Short-Term Debt | 411,162 | 367,092 | 315,447 | 182,000 | 104,836 | 203,200 | Upgrade
|
| Current Portion of Long-Term Debt | 255,066 | 10,829 | 202,813 | 5,416 | 120,539 | 91,175 | Upgrade
|
| Current Portion of Leases | 15,434 | 14,304 | 14,335 | 11,580 | 9,887 | 7,505 | Upgrade
|
| Current Income Taxes Payable | 11,505 | 7,873 | 2,041 | 17,158 | 28,338 | 11,663 | Upgrade
|
| Current Unearned Revenue | 524 | 2,025 | 1,629 | 7,084 | 7,730 | 582 | Upgrade
|
| Other Current Liabilities | 260,278 | 170,461 | 154,835 | 94,165 | 76,231 | 57,810 | Upgrade
|
| Total Current Liabilities | 1,270,873 | 769,475 | 868,917 | 540,738 | 552,883 | 589,403 | Upgrade
|
| Long-Term Debt | 232,805 | 339,506 | 84,891 | 278,797 | 280,343 | 194,160 | Upgrade
|
| Long-Term Leases | 108,450 | 96,412 | 106,536 | 97,751 | 90,969 | 70,392 | Upgrade
|
| Long-Term Unearned Revenue | 7,295 | 7,400 | 7,500 | 14,049 | 16,296 | 5,606 | Upgrade
|
| Pension & Post-Retirement Benefits | 38,311 | 16,805 | 1,356 | 1,171 | 1,497 | 5,711 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 12,985 | 4,063 | 2,213 | 1,358 | 1,869 | 1,876 | Upgrade
|
| Other Long-Term Liabilities | 31,331 | 29,200 | 32,038 | 25,031 | 18,531 | 14,946 | Upgrade
|
| Total Liabilities | 1,702,049 | 1,262,860 | 1,103,451 | 958,895 | 962,388 | 882,094 | Upgrade
|
| Common Stock | 58,433 | 58,433 | 58,433 | 58,433 | 58,433 | 58,433 | Upgrade
|
| Additional Paid-In Capital | 396,224 | 396,220 | 393,605 | 393,531 | 385,821 | 337,016 | Upgrade
|
| Retained Earnings | 881,845 | 815,336 | 872,989 | 903,467 | 867,353 | 757,278 | Upgrade
|
| Treasury Stock | -35,702 | -35,702 | -35,702 | -35,702 | -35,702 | -35,702 | Upgrade
|
| Comprehensive Income & Other | -1,484 | 18,358 | 10,912 | 8,394 | -1,134 | 1,498 | Upgrade
|
| Total Common Equity | 1,299,317 | 1,252,645 | 1,300,236 | 1,328,122 | 1,274,771 | 1,118,524 | Upgrade
|
| Minority Interest | 190,162 | 228,371 | 239,627 | 238,520 | 224,987 | 150,782 | Upgrade
|
| Shareholders' Equity | 1,489,479 | 1,481,016 | 1,539,863 | 1,566,642 | 1,499,757 | 1,269,306 | Upgrade
|
| Total Liabilities & Equity | 3,191,528 | 2,743,876 | 2,643,314 | 2,525,537 | 2,462,145 | 2,151,400 | Upgrade
|
| Total Debt | 1,022,917 | 828,142 | 724,022 | 575,543 | 606,574 | 566,432 | Upgrade
|
| Net Cash (Debt) | -954,400 | -804,147 | -668,516 | -463,238 | -403,639 | -310,934 | Upgrade
|
| Net Cash Per Share | -83520.42 | -70457.79 | -58574.02 | -40587.96 | -35366.01 | -27243.38 | Upgrade
|
| Filing Date Shares Outstanding | 11.41 | 11.41 | 11.41 | 11.41 | 11.41 | 11.41 | Upgrade
|
| Total Common Shares Outstanding | 11.41 | 11.41 | 11.41 | 11.41 | 11.41 | 11.41 | Upgrade
|
| Working Capital | 223,614 | 432,358 | 170,231 | 439,698 | 537,637 | 542,639 | Upgrade
|
| Book Value Per Share | 113843.54 | 109754.26 | 113924.12 | 116367.45 | 111692.86 | 98002.82 | Upgrade
|
| Tangible Book Value | 860,979 | 1,054,496 | 1,071,595 | 1,108,912 | 1,075,056 | 1,076,662 | Upgrade
|
| Tangible Book Value Per Share | 75437.26 | 92392.82 | 93891.05 | 97160.69 | 94194.24 | 94334.96 | Upgrade
|
| Land | - | 17,509 | 17,346 | 17,383 | 18,025 | 17,976 | Upgrade
|
| Buildings | - | 705,071 | 695,794 | 638,353 | 572,756 | 508,734 | Upgrade
|
| Machinery | - | 430,546 | 407,055 | 369,503 | 333,326 | 310,115 | Upgrade
|
| Construction In Progress | - | 43,028 | 59,224 | 103,334 | 150,176 | 85,095 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.